Search Results

3DMem is the world’s first company to commercialize 3D-nanoprinting technology, for membrane manufacturing. We develop ideal membranes and deliver precise filtration performance through our smart factory platform.

PrintBio is deploying technologies utilized to manufacture and implant the first 3D-bioprinted living tissues in patients. PrintBio is the only clinical-stage regenerative medicine company solving medical challenges with custom-engineered 3D-bioprinted living implants. Leveraging first in human clinical experience, PrintBio is developing an array of products, beginning with 3DMatrix™, a 3D-printed monofilament bioresorbable surgical mesh (pending 510(k) FDA approval), utilizing its proprietary technologies clinically tested in patients.

Clecell, Inc. commercializes the core 3D bioprinting technology developed by a Harvard Medical School team for over a decade. Clecell manufactures 3D human tissues for regenerative and precision medicine, and develops a clinical simulation platform based on these technologies.

GenesisTissue Inc. is a 3D bioprinting tissue company that designs and manufactures personalized regenerative tissue implants for humans

Advance Your Discoveries with Customised Bioprinting Solutions Transform your research with bioprinters that adapt to meet the precise needs of every project. Experience technology that evolves as rapidly as your discoveries Discover Our Bioprinters Introduction Welcome to Next Big Innovation Labs®, where we harness the power of bioprinting technology to fuel scientific discovery and innovation. At NBIL, we are dedicated to providing researchers & clinician with tools that are not only technologically advanced but also intuitive and adaptable. Our Trivima series of bioprinters are designed to cater to all levels of research expertise, enabling groundbreaking work in tissue engineering, regenerative medicine, and more. Dive into our world of bioprinting, where we make complex scientific challenges simpler and more achievable.

Using our proprietary, tunable, and tissue-specific bioinks we are developing a library of 3D tumor models that replicate key aspects associated with cancer growth and metastasis.

We envision a future where biofabrication is as simple and intuitive as pressing a button empowering researchers and companies to focus on breakthroughs.

AddPark is a technology company that specializes in developing high-tech industrial products using advanced manufacturing technologies and innovative design techniques. Our contracted production services utilize metal additive manufacturing and performance polymers, and we also offer technical training and on-device training programs to accelerate learning in additive manufacturing.

We have a full suite of 3D printing manufacturing equipment. Our team brings materials and manufacturing expertise to ensure we produce a part that meets your engineering needs.

Lab14 is a leader in advanced manufacturing solutions, specializing in nanofabrication, microfabrication and surface analysis technologies.

We develop and implement innovative technological solutions based on biomaterials for the pharmaceutical, medical, and cosmetics industries. We specialize in chitosan and microcrystalline chitosan. We cooperate with scientists who have studied chitosan and its processing technologies in detail for many years.

We are a biodesign studio combining methods of microbiology and computational design technologies with expertise in 3D printed and robotically fabricated biomaterials. Our work sets out to uncover and highlight the beauty, intelligence, and complexity of microbial life for design systems. Our aim is to make products that reduce natural resources extraction and consumption, promoting long-term environmental health.

We are a biotechnology company that provides advanced solutions for medical research, drug discovery and regenerative medicine by integrating cutting-edge 3D bioprinting technology, biology expertise and a deep understanding of market needs, positioning us as a valuable asset for healthcare and biotech industries

Our unique 4D-Fibroprinting technology enables our customers to produce artificial living tissues with personalized shapes, personalized cells as well as natural fibrillar and vascular structures.

Systemic Bio is a 3D Systems company based in Houston, Texas, focused on the development of vascularized organ models made out of hydrogels and human cells to be used for drug discovery and development.

Originating at MIT Media Lab, OPT Industries was founded with the goal of pushing the design and production limitations of digital manufacturing. Drawing inspiration from nature and mass manufacturing, we provide novel materials for visual appeal and engineered applications.

Trestle Biotherapeutics, Inc. is a pre-clinical stage company developing bioengineered therapies for patients living with end stage renal disease. Once implanted, these bioengineered stem cell-derived tissues will get patients off dialysis, delay their need for transplantation, and one day become replacement organs.

We are a deep-tech company specializing in research and development projects with the use of additive technologies. Let's get in touch!

Lattice Medical is a biomedical start-up that was launched in October 2017 Patented 3D technology developed with CHU Lille-France that allows adipose tissue to naturally regenerate

At Inventia, we’re creating some of the most powerful tools for advanced medical discovery today.